Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.7401
+0.0185 (2.56%)
At close: May 12, 2025, 4:00 PM
0.7400
-0.0001 (-0.01%)
After-hours: May 12, 2025, 6:50 PM EDT
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $45.12 million as of May 12, 2025. Its market cap has decreased by -21.78% in one year.
Market Cap
45.12M
Enterprise Value
-30.52M
1-Year Change
-21.78%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $45.12M, a decrease of -95.50%. That is a compound annual growth rate of -49.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 44.00M | -23.25% |
| Dec 31, 2024 | 57.32M | -21.36% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.75B |
| Johnson & Johnson | 372.82B |
| UnitedHealth Group | 343.19B |
| AbbVie | 338.81B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.65B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |